Acute Kidney Failure Clinical Trial
— HAND-OUTOfficial title:
The Hannover-Dialysis-Outcome (HAN-D-OUT)-Study: Comparison of Standard Versus Intensified Extended Dialysis in Treatment of Patients With Acute Kidney Injury in the Intensive-Care Unit
Verified date | September 2007 |
Source | Hannover Medical School |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Interventional |
Mortality rates of patients with acute kidney injury in the intensive care unit have changed little over the past few decades despite significant advances in supportive care. Few interventions have been shown to result in an improvement of in-hospital mortality of these patients, with dose of renal replacement therapy (RRT) being one of the most important. Patients undergoing continuous veno-venous hemofiltration had better outcomes with ultrafiltration rates of 35 mL/kg/h or 45 mL/kg/h than those treated at a rate of 20 mL/kg/h. In a different trial, intermittent hemodialysis on a daily basis resulted in better control of uremia, fewer hypotensive episodes during dialysis, and more rapid resolution of acute renal failure than thrice weekly hemodialysis. In the present study we examine survival and renal recovery in critically ill patients with acute kidney injury that are treated with a currently recommended (standard) dose of RRT, and patients that receive intensified RRT.
Status | Completed |
Enrollment | 157 |
Est. completion date | May 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - non post-renal AKI with RRT dependency indicated by oliguria/anuria <30mL/h >6 hours prior to inclusion - loss of kidney function of >30% within 48 hours prior to inclusion - hyperkalemia >6.5 mmol/L - severe acidosis with pH<7.15 Exclusion Criteria: - pre-existing chronic kidney disease (CKD) as defined by an estimated glomerular filtration rate <50mL/min or a plasma creatinine concentration >1.7 mg/dL (>150 µmol/L) more than 10 days prior to initiation of the first RRT - presence of AV-fistula or dialysis catheter - participation in another study - consent denial or withdrawal - need for extra corporal membrane oxygenation therapy. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | Hannover Medical School | Hannover |
Lead Sponsor | Collaborator |
---|---|
Hannover Medical School | Fresenius AG |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Survival | Day 14 after initiation of renal replacement therapy | ||
Secondary | Survival and renal recovery | Day 28 after initiation of renal replacement therapy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00760591 -
Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study)
|
N/A | |
Completed |
NCT00890214 -
Prostacyclin's Effect on Platelet Responsiveness
|
Phase 4 | |
Active, not recruiting |
NCT03675906 -
The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
|
||
Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
Recruiting |
NCT00424320 -
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
|
Phase 3 | |
Completed |
NCT00472563 -
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
|
Phase 2/Phase 3 | |
Withdrawn |
NCT03846258 -
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
|
Phase 4 | |
Completed |
NCT06358365 -
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
|
N/A | |
Completed |
NCT00252200 -
BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.
|
Phase 1/Phase 2 | |
Completed |
NCT04190979 -
Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA)
|
N/A | |
Completed |
NCT04917497 -
Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
|
||
Recruiting |
NCT05309291 -
Theranova Randomized, Controlled, Trial (RCT) in China
|
N/A | |
Completed |
NCT02486614 -
Effect of Citrate on the Coagulation System in Patients Receiving CRRT
|
||
Active, not recruiting |
NCT02470507 -
Immune Function in Acute Kidney Injury
|
||
Active, not recruiting |
NCT05384899 -
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
|
||
Completed |
NCT06190522 -
Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
|
||
Recruiting |
NCT04221932 -
Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"
|
||
Active, not recruiting |
NCT01122225 -
Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury
|
N/A | |
Recruiting |
NCT04445779 -
Q10 Preloading Before Cardiac Surgery for Kidney Failure Reduction
|
N/A |